Associations of genetic and infectious risk factors with coronary heart disease.
Cox regression
coronary heart disease
genetics
genomics
human
human genomics
inflammation
persistent infections
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
14 02 2023
14 02 2023
Historique:
received:
25
04
2022
accepted:
22
01
2023
entrez:
14
2
2023
pubmed:
15
2
2023
medline:
16
2
2023
Statut:
epublish
Résumé
Coronary heart disease (CHD) is one of the most pressing health problems of our time and a major cause of preventable death. CHD results from complex interactions between genetic and environmental factors. Using multiplex serological testing for persistent or frequently recurring infections and genome-wide analysis in a prospective population study, we delineate the respective and combined influences of genetic variation, infections, and low-grade inflammation on the risk of incident CHD. Study participants are enrolled in the CoLaus|PsyCoLaus study, a longitudinal, population-based cohort with baseline assessments from 2003 through 2008 and follow-up visits every 5 years. We analyzed a subgroup of 3459 individuals with available genome-wide genotyping data and immunoglobulin G levels for 22 persistent or frequently recurring pathogens. All reported CHD events were evaluated by a panel of specialists. We identified independent associations with incident CHD using univariable and multivariable stepwise Cox proportional hazards regression analyses. Of the 3459 study participants, 210 (6.07%) had at least one CHD event during the 12 years of follow-up. Multivariable stepwise Cox regression analysis, adjusted for known cardiovascular risk factors, socioeconomic status, and statin intake, revealed that high polygenic risk (hazard ratio [HR] 1.31, 95% CI 1.10-1.56, p=2.64 × 10
Identifiants
pubmed: 36785929
doi: 10.7554/eLife.79742
pii: 79742
pmc: PMC9928420
doi:
pii:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023, Hodel et al.
Déclaration de conflit d'intérêts
FH, ZX, CT, Rd, PL, NB, JB, NB, TW, PM, PV, JV, JF No competing interests declared
Références
JAMA. 2003 Aug 20;290(7):898-904
pubmed: 12928466
F1000Prime Rep. 2015 Jan 14;7:08
pubmed: 25705391
JAMA. 1995 Jul 12;274(2):131-6
pubmed: 7596000
Am J Med. 1984 Feb 27;76(2A):4-12
pubmed: 6702862
Lancet. 1990 Mar 31;335(8692):765-74
pubmed: 1969518
Helicobacter. 2009 Dec;14(6):525-35
pubmed: 19889070
J Am Coll Cardiol. 2018 Oct 16;72(16):1883-1893
pubmed: 30309464
BMC Infect Dis. 2013 Jun 05;13:264
pubmed: 23734900
Int J Cancer. 2016 Apr 1;138(7):1670-9
pubmed: 26537841
Virus Evol. 2021 Jun 11;7(2):veab058
pubmed: 34532061
Arch Med Res. 2015 Jul;46(5):339-50
pubmed: 26004263
Annu Rev Genet. 2013;47:75-95
pubmed: 23988118
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
Nat Genet. 2021 Apr;53(4):420-425
pubmed: 33692568
Adv Exp Med Biol. 1990;273:27-37
pubmed: 2288281
J Immunol Methods. 2006 Feb 20;309(1-2):200-4
pubmed: 16406059
PLoS One. 2020 Apr 22;15(4):e0231974
pubmed: 32320435
Sex Transm Infect. 2004 Oct;80(5):354-62
pubmed: 15459402
Methods. 2019 Apr 1;158:44-53
pubmed: 30703462
PLoS One. 2019 Jan 7;14(1):e0210407
pubmed: 30615688
Eur Heart J. 2021 Jul 1;42(25):2439-2454
pubmed: 34120177
Int J Cancer. 2007 Jun 1;120(11):2459-65
pubmed: 17315193
Diabetes Care. 1993 Feb;16(2):434-44
pubmed: 8432214
Infect Immun. 2004 Apr;72(4):2272-9
pubmed: 15039352
PLoS One. 2015 Oct 28;10(10):e0140765
pubmed: 26510007
Clin Chem. 2005 Oct;51(10):1845-53
pubmed: 16099939
Eur Heart J. 2021 Jul 1;42(25):2455-2467
pubmed: 34120185
Am J Prev Cardiol. 2020 Nov 21;4:100130
pubmed: 34327481
J Natl Cancer Inst. 2019 Feb 1;111(2):129-136
pubmed: 29790947
PLoS One. 2011;6(6):e21002
pubmed: 21695270
J Dent Res. 2013 Jun;92(6):485-91
pubmed: 23625375
Front Cardiovasc Med. 2021 Jan 15;7:625579
pubmed: 33521070
PLoS One. 2018 Dec 27;13(12):e0209379
pubmed: 30589867
N Engl J Med. 2007 Aug 2;357(5):443-53
pubmed: 17634449
Sci Rep. 2022 Jan 24;12(1):1241
pubmed: 35075206
Front Immunol. 2019 Nov 26;10:2715
pubmed: 32038605
Lancet. 1988 Oct 29;2(8618):983-6
pubmed: 2902492
Circulation. 2016 Mar 22;133(12):1181-8
pubmed: 26915630
Eur Heart J. 2003 Jun;24(11):987-1003
pubmed: 12788299
J Periodontal Res. 2008 Apr;43(2):224-31
pubmed: 18326058
Int J Cancer. 2018 Aug 1;143(3):570-579
pubmed: 29574937
Curr Opin Microbiol. 2015 Feb;23:141-7
pubmed: 25576662
Am J Epidemiol. 2016 Jan 1;183(1):61-9
pubmed: 26667254
World J Gastroenterol. 2018 Nov 7;24(41):4617-4621
pubmed: 30416309
J Periodontol. 2011 Oct;82(10):1469-77
pubmed: 21453047
Am J Clin Nutr. 2006 Feb;83(2):456S-460S
pubmed: 16470012
Oral Microbiol Immunol. 2006 Aug;21(4):206-11
pubmed: 16842503
Cancer Epidemiol Biomarkers Prev. 2019 Sep;28(9):1552-1555
pubmed: 31481495
Helicobacter. 2020 Dec;25(6):e12761
pubmed: 33026704
N Engl J Med. 2005 Apr 21;352(16):1685-95
pubmed: 15843671
Int J Cancer. 2017 Sep 1;141(5):897-904
pubmed: 28477334
J Gen Virol. 2015 Aug;96(8):2286-2292
pubmed: 25920529
Mediators Inflamm. 2015;2015:378658
pubmed: 26346892
Int J Cardiol. 2013 Jul 1;166(3):572-83
pubmed: 22727974
BMC Cardiovasc Disord. 2011 Nov 03;11:66
pubmed: 22151179
N Engl J Med. 1994 Apr 14;330(15):1041-6
pubmed: 8127331
Chin Med J (Engl). 2008 May 20;121(10):946-51
pubmed: 18706211
BMC Cardiovasc Disord. 2008 Mar 17;8:6
pubmed: 18366642
Eur Heart J. 2016 Nov 14;37(43):3267-3278
pubmed: 27655226
Nat Protoc. 2020 Sep;15(9):2759-2772
pubmed: 32709988
Trends Endocrinol Metab. 2015 Jun;26(6):315-21
pubmed: 25892452
Eur J Prev Cardiol. 2021 Apr 10;28(2):204–210
pubmed: 33838036